Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$386879.0.

  • Cumberland Pharmaceuticals' Cash from Financing Activities rose 2793.35% to -$386879.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 853954.21%. This contributed to the annual value of $196904.0 for FY2024, which is 10265.21% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Cash from Financing Activities stood at -$386879.0, which was up 2793.35% from -$150797.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Cash from Financing Activities registered a high of $3.9 million during Q1 2022, and its lowest value of -$5.5 million during Q1 2025.
  • For the 5-year period, Cumberland Pharmaceuticals' Cash from Financing Activities averaged around -$995087.5, with its median value being -$1.2 million (2022).
  • Within the past 5 years, the most significant YoY rise in Cumberland Pharmaceuticals' Cash from Financing Activities was 40185.87% (2022), while the steepest drop was 61985.77% (2022).
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Cash from Financing Activities stood at -$735300.0 in 2021, then tumbled by 278.19% to -$2.8 million in 2022, then surged by 46.52% to -$1.5 million in 2023, then rose by 7.31% to -$1.4 million in 2024, then surged by 71.93% to -$386879.0 in 2025.
  • Its last three reported values are -$386879.0 in Q3 2025, -$150797.0 for Q2 2025, and -$5.5 million during Q1 2025.